News Agency
Men's Weekly

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

  • Written by Media Outreach
SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc. to launch and commercialise Libtayo® (cemiplimab), a fully human monoclonal antibody...

Read more: Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South...

Furniture Movers Sydney: Complete Guide to Safe and Efficient Moving

Moving furniture in a busy city like Sydney can be a complex task. High rise apartments, narrow streets, traffic congestion, and strict building regulations all add extra challenges to the moving process. Whether you are relocating your home or office... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion